132 related articles for article (PubMed ID: 8358281)
1. Self-administered faecal occult blood tests do not increase compliance with screening for colorectal cancer: results of a randomized controlled trial.
Verne J; Kettner J; Mant D; Farmer A; Mortenson N; Northover J
Eur J Cancer Prev; 1993 Jul; 2(4):301-5. PubMed ID: 8358281
[TBL] [Abstract][Full Text] [Related]
2. Patient compliance with colorectal cancer screening in general practice.
Mant D; Fuller A; Northover J; Astrop P; Chivers A; Crockett A; Clements S; Lawrence M
Br J Gen Pract; 1992 Jan; 42(354):18-20. PubMed ID: 1586526
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Coloscreen Self-Test and Haemoccult faecal occult blood tests in the detection of colorectal cancer in symptomatic patients.
Pye G; Jackson J; Thomas WM; Hardcastle JD
Br J Surg; 1990 Jun; 77(6):630-1. PubMed ID: 2200550
[TBL] [Abstract][Full Text] [Related]
4. Is there a preference for different ways of performing faecal occult blood tests?
Kettner JD; Whatrup C; Verne JE; Young K; Williams CB; Northover JM
Int J Colorectal Dis; 1990 May; 5(2):82-6. PubMed ID: 2242119
[TBL] [Abstract][Full Text] [Related]
5. Does use of the Coloscreen Self-Test improve patient compliance with fecal occult blood screening?
Park SI; Saxe JC; Weesner RE
Am J Gastroenterol; 1993 Sep; 88(9):1391-4. PubMed ID: 8362837
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting compliance in colorectal cancer screening. Results of a study performed in Ballarat.
Macrae FA; St John DJ; Ambikapathy A; Sharpe K; Garner JF
Med J Aust; 1986 Jun; 144(12):621-3. PubMed ID: 3713601
[TBL] [Abstract][Full Text] [Related]
7. The effect of self-administered faecal occult blood tests on compliance with screening for colorectal cancer: results of a survey of those invited.
Hunter W; Farmer A; Mant D; Verne J; Northover J; Fitzpatrick R
Fam Pract; 1991 Dec; 8(4):367-72. PubMed ID: 1800202
[TBL] [Abstract][Full Text] [Related]
8. Intervention in large bowel carcinogenesis--does screening improve prognosis?
Farrands PA; Britton DC
Scand J Gastroenterol Suppl; 1984; 104():151-9. PubMed ID: 6597547
[TBL] [Abstract][Full Text] [Related]
9. Screening for colorectal carcinoma: an analysis of the sensitivity of haemoccult.
Thomas WM; Pye G; Hardcastle JD; Walker AR
Br J Surg; 1992 Aug; 79(8):833-5. PubMed ID: 1393487
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of results of guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening in two oncological institutions.
Castiglione G; Sala P; Ciatto S; Grazzini G; Mazzotta A; Rossetti C; Spinelli P; Bertario L
Eur J Cancer Prev; 1994 Sep; 3(5):399-405. PubMed ID: 8000308
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
Hardcastle JD; Chamberlain JO; Robinson MH; Moss SM; Amar SS; Balfour TW; James PD; Mangham CM
Lancet; 1996 Nov; 348(9040):1472-7. PubMed ID: 8942775
[TBL] [Abstract][Full Text] [Related]
12. [A randomized controlled trial to motivate worksite fecal occult blood testing].
Lee CY
Kanho Hakhoe Chi; 1990 Dec; 20(3):300-6. PubMed ID: 2290245
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of RPHA fecal occult blood test in screening for colorectal cancer].
Yu H
Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):108-10. PubMed ID: 2401172
[TBL] [Abstract][Full Text] [Related]
14. Haemoccult screening for colorectal cancer: the effect of dietary restriction on compliance.
Robinson MH; Pye G; Thomas WM; Hardcastle JD; Mangham CM
Eur J Surg Oncol; 1994 Oct; 20(5):545-8. PubMed ID: 7926056
[TBL] [Abstract][Full Text] [Related]
15. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests.
Thomas WM; Pye G; Hardcastle JD; Mangham CM
Br J Surg; 1990 Mar; 77(3):277-9. PubMed ID: 2322789
[TBL] [Abstract][Full Text] [Related]
16. [Haemoscreen in comparison with haemoccult as screening test for colorectal carcinoma (author's transl)].
Gnauck R; Thomas L
Dtsch Med Wochenschr; 1980 Nov; 105(47):1643-6. PubMed ID: 7439045
[TBL] [Abstract][Full Text] [Related]
17. A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload.
Pye G; Christie M; Chamberlain JO; Moss SM; Hardcastle JD
J Epidemiol Community Health; 1988 Mar; 42(1):66-71. PubMed ID: 3418289
[TBL] [Abstract][Full Text] [Related]
18. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme.
Hart AR; Eaden J; Barnett S; de Bono AM; Mayberry JF
J Epidemiol Community Health; 1998 Dec; 52(12):818-20. PubMed ID: 10396524
[TBL] [Abstract][Full Text] [Related]
20. Role of dietary restriction in Haemoccult screening for colorectal cancer.
Thomas WM; Pye G; Hardcastle JD; Chamberlain J; Charnley RM
Br J Surg; 1989 Sep; 76(9):976-8. PubMed ID: 2679967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
